COVID-19 Grants and Funding News

Important news from NIH for grantees and grant applicants on the novel coronavirus SARS-CoV-2 and coronavirus disease 2019 (COVID-19).

• Funding opportunities specific to COVID-19 from the NIH Office of Extramural Research (OER)
• COVID-19 information for NIH grant applicants and grant recipients, including NIH funding opportunities specific to COVID-19 from the NIH Office of Extramural Research (OER)
• Coronavirus news, funding and resources for global health researchers compiled by Fogarty

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration.

• New >Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa), an NIH Common Fund program:
  • Research Training Program (U2R - Clinical Trial Optional) (RFA-RM-20-016)
    Application Due Date: November 24, 2020
  • Ethical, Legal, and Social Implications Research (U01 Clinical Trial Not Allowed) (RFA-RM-20-017)
    Application Due Date: December 1, 2020
  • Open Data Science Platform and Coordinating Center (U2C Clinical Trial Not Allowed) (RFA-RM-20-018)
    Application Due Date: December 3, 2020
  • Research Hubs (U54Clinical Trial Optional) (RFA-RM-20-015)
    Non-AIDS Application Due Date: December 8, 2020
    AIDS Application Due Date: February 8, 2021
  • The NIH Common Fund will host DS-I Africa technical assistance webinars August 10, 2020. See the related NIH Guide notice NOT-RM-20-024 for details.
  • Register now and join the DS-I Africa Virtual Symposium Platformfor keynote presentations, interactive panels and networking opportunities. Events begin 9 am ET on Monday, Aug. 10.
• Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium:
  Field Epidemiology Sites (U01 - Clinical Trial Not Allowed) (RFA-DK-20-017)
  Renal Science Core (U01 - Clinical Trial Not Allowed) (RFA-DK-20-018)
  Scientific Data Coordinating Center (SDCC) (U24 - Clinical Trial Not Allowed) (RFA-DK-20-019)
  Fogarty is participating in the Field Epidemiology Sites.
  Application Due Date: November 10, 2020
  NIDDK will host a pre-application webinar on August 17, 2020. Advance registration is required. See the related NIH Guide notice NOT-DK-20-037 for details.
  
  
• Reissue of Ethical, Legal and Social Implications (ELSI) research:
  Research Project Grant (R01 Clinical Trial Optional) (PAR-20-254)
  Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) (Clinical Trial Optional) (PAR-20-255)
  Small Research Grant (R03) Clinical Trial Optional) (PAR-20-257)
  Fogarty is interested in supporting research on ethical issues related to human genome research relevant to low- and middle-income countries, in particular, studies conducted by investigators in these countries, through the Small Research Grant Program (R03) (PA-20-257).Application Due Dates: October 19 2020, February 17 2021, and more.

NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.

• Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional) (PAR-20-279)
  Application Receipt Dates: December 15, 2020; August 10, 2021; and more
• Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional) (RFA-AG-21-029)
  Application Receipt Date: November 10, 2020
• Investigator-Initiated Research on Genetic Counseling Processes and Practices (R01, Clinical Trial Optional) (RFA-HG-20-048) and (R21, Clinical Trial Optional) (RFA-HG-20-049)
  Application Receipt Dates: October 28, 2020 and July 8, 2021
• Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional) (PAR-20-281) and (R21 Clinical Trial Not Allowed) (PAR-20-282)
  Application Receipt Dates: October 19, 2020; June 19, 2021; and more
• Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) (PAR-20-271)
  Application Receipt Dates: Standard dates apply.
• Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) (PAR-20-276) and (R21 Clinical Trials Not Allowed) (PAR-20-277)
  Application Receipt Dates: Standard dates apply.

NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers.

• Notice of Special Interest: Fundamental and Translational Research on Decision Making in Aging and/or Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) (NOT-AG-20-039)
• Notice of Special Interest (NOSI): Improving Methods to Assess Body Composition in Infants and Young Children (NOT-DK-20-036)

Information related to opportunities from other organizations focusing on global health and foreign collaboration.

• Grant to Activate Global Engagement (GAGE) from the American Neurological Association will provide up to $1,500 to support attendance at its 2020 virtual annual meeting. Awards are open to organizations or groups of neurologists or neurology trainees engaged in clinical care, research or medical education in a low-income or lower-middle-income country settings whose practice is focused on the care of children or adults with neurological disorders.
  Application deadline: August 31, 2020

Featured Fogarty News and Information

• NIH to invest $58M to catalyze data science and innovation in Africa

• View all Fogarty news

• View and subscribe to Fogarty's Global Health Matters e-newsletter